Medical Marijuana Market Size By Application (Pain Management, Muscle Spasms, Nausea, Anorexia, Seizures, Others), By Route of Administration (Inhalation, Oral, Topical), By Distribution Channel (Dispensaries, Online), Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, Italy, UK, Czech Republic, France, The Netherlands, Argentina, Chile, Peru, Colombia, Australia, Israel) Application Potential, Price Trends, Competitive Market Share & Forecast, 2018 – 2024

Published Date: Aug 2018  |  Report ID: GMI2836  |  Authors: Sumant Ugalmugale, Rupali Swain

Report Format: PDF   |   Pages: 150   |   Base Year: 2017

Summary Table of Contents Industry Coverage Methodology

Industry Trends

Medical Marijuana Market size was valued over USD 7.0 billion in 2017 and is expected to witness more than 36.0% CAGR from 2018 to 2024.

U.S. Medical Marijuana Market, By Application, 2013 – 2024 (USD Billion)

Get more details on this report - Request Free Sample PDF

Increasing use of marijuana in therapeutic applications such as pain management in neurology, cancer, HIV/AIDS, seizures, muscle spasms, and nausea will drive the medical marijuana market growth. Marijuana is effective in treating chronic pain that affects millions of Americans each year, hence demand for the same is increasing for treatment of medical conditions. According to the most recent estimates by the National Health Interview Survey (NHIS), around 25 million people suffer from pain daily in the US. Furthermore, a number of countries around the globe have passed laws that would allow the population to use marijuana for medical purposes; therefore, medical marijuana market should expand rapidly in near future.

Research on marijuana's potential for medicinal use is on an upsurge in various parts of the world. In February 2018, WeedMD, a licensed Canadian medical marijuana producer, announced its partnership with the cannabis database project controlled by the Technion-Israel Institute of Technology (TIT). The collaborative entity would research cannabinoid and terpenoid profiles of 25 of WeedMD’s cannabis strains. Similarly, in 2017, Oxford University announced its partnership with private equity company, Kingsley Capital Partners, for developing novel cannabis treatments for pain, cancer and inflammatory diseases. These research studies will result in number of product approvals for various medical conditions and hence have a positive impact on the medical marijuana market growth.

Few side effects such as fatigue, dizziness, insomnia, speech problems and constipation associated with medical marijuana are most likely to restrain medical marijuana market size expansion. In addition, lack of safety data and difficulty in undertaking medical marijuana business is also estimated to hinder the medical marijuana industry growth.

Medical Marijuana Market Report Coverage
Report Coverage Details
Base Year: 2017
Historical Data for: 2013 to 2017 Forecast Period: 2018 to 2024
Pages: 150 Tables, Charts & Figures: 170
Geographies covered (14): U.S., Canada, Germany, Italy, UK, Czech Republic, France, The Netherlands, Argentina, Chile, Peru, Colombia, Australia, Israel
Segments covered: Application, Route of Administration, Distribution Channel and Region
Companies covered (21): Canopy Growth, Aphria, Inc., Aurora Cannabis, Inc., GW Pharmaceuticals, mCig, Medical Marijuana, Inc., United Cannabis, MedReleaf, The Supreme Cannabis Company, CanniMed Ltd., Medical Marijuana, Inc., Tilray, Emerald Health Therapeutics, Lexaria Corporation, Cannabis Sativa, Inc., Insys Therapeutics, Inc., Corbus Pharmaceuticals, GBSciences, Inc., The Cronos Group, The Hydropothecary Corporation, Namaste Technologies Inc

Request 15% Free Customization on this Report

Medical Marijuana Market, By Application

Medical marijuana pain management market held around 75% share of total application market valuation, accounting for a total value of USD 5,481.1 million 2017. Being one of the biggest health problems, Chronic pain management using marijuana happens to be its largest application area. According to past research studies, 1 in 10 adults are diagnosed with chronic pain each year; with increasing success from marijuana in pain management, the demand for the same should increase multi-folds during the forecast period. Neuropathic pain captured the largest market share in 2017 due to increased number of peripheral neuropathy cases. Also, marijuana being an effective treatment for neuropathic pain, its use will further rise over the forecast timeframe.

The medical marijuana market for skin-related conditions such as eczema and psoriasis, is estimated to show lucrative growth in near future; in fact, is estimated to expand at 37.4% CAGR from 2018-2024. Various research studies have shown that cannabinoids, one of the active ingredients of marijuana, may help regulate inflammation and immune function, hence increasing their application in due course of time. Millions of people affected with serious skin diseases should prove to be a potentially massive target market in near future.

Medical Marijuana Market, By Route of Administration

Medical marijuana inhalation market segment accounted for USD 5,330.0 million 2017. Due to its various advantages such as controlled dosage and effective absorption of cannabinoids into the body, the demand for inhalation marijuana should only increase over the coming years.

Topical medical marijuana market is estimated to grow at a CAGR of 37.2% during the forecast period. The growing demand of marijuana topical ointments, lotions, creams, gels, or poultice for the treatment of skin inflammations will result in market expansion. With number of products in pipeline, more products are expected to enter into the market in near future. For instance, in 2017, Zynerba Pharmaceutical’s phase II trials using a topical cannabinoid gel for seizures and osteoarthritis was found to be safe and well-tolerated. Further research and investigation would validate the clinical application of topical marijuana products, thereby accentuating the industry growth.

Medical Marijuana Market, By Distribution Channel

The medical marijuana dispensaries market segment generated value of USD 4,368.9 million in 2017. Marijuana dispensaries are regulated by the local government providing a range of products to prescribed patients who have been granted permission from a healthcare practitioner. Such dispensaries sell various legal medical cannabis products which are in the form of vaporizers, tablets, elixirs, balms, and tinctures. Major patient population prefer buying medical marijuana products from legal and authorized dispensaries to comply and abide by their local government’s rules, thereby maximizing the marijuana dispensaries revenue.

Online medical marijuana market is forecasted to expand with a 36.8% CAGR during 2018-2024. Increasing demand from number of states and countries to legalize medical marijuana in the long run would fetch more orders online as it would get very convenient for patients to opt for mail orders. Furthermore, online orders for medical marijuana would make the whole buying process completely private and discreet, which is preferred by medical marijuana patients; thus, with online marijuana selling approvals, the industry should expand significantly over the coming years.

Medical Marijuana Market, By Region

U.S. medical marijuana market valued USD 3,549.0 million in 2017 and will grow multi-folds in near future owing to increasing medical marijuana applications. As of 2018, 30 U.S. states and Washington DC have allowed the application of medical marijuana. Also, growing number of research studies in the US, supporting marijuana's use for medical purposes should supplement the North American medical marijuana market growth.

Germany medical marijuana market is estimated to expand at 49.5% CAGR during the forecast period. Being one of the early adopters and first to legalize medical marijuana in 2017, Germany cannabis industry is the largest in Europe. Large population with diverse demographics is attracting various medical cannabis companies to invest in Germany, thereby resulting in industry expansion.

Competitive Market Share

Some of the leading key players in the industry include Canopy Growth, Aurora Cannabis, Inc., Medical Marijuana, Inc., GW Pharmaceuticals, Aphria, Inc., CanniMed Ltd., Tilray, Emerald Health Therapeutics, and MedReleaf Corp. Number of companies are opting for mergers, acquisitions and partnerships to increase their geographic reach, product portfolio and position in the market. For instance, in May 2017, Aurora Cannabis, a Canadian licensed cannabis producer, acquired Pedanios GmbH, a German wholesale medical cannabis company which supplies products to more than 750 pharmacies in the Europe. Similarly, in April 2018, Canopy Growth announced its plan to acquire Annabis Medical s.r.o., a medical cannabis distributor based in Czech Republic. Such acquisitions have resulted in the expansion of medical cannabis companies with a strong footprint and established distribution network.

Medical Marijuana Industry Background

Medical marijuana industry is still in its nascent stage and will develop significantly in the coming years. US and Europe are the two largest regions operating in the medical marijuana market. These regions have varying levels of laws and regulations pertaining to the application of medical marijuana. As marijuana is still classified as Schedule I drug, various countries are yet to legalize it for medicinal purposes. However, majority of nations are in favour of getting medicinal marijuana legalized owing to therapeutic efficacy of products for the treatment of various chronic pain conditions, seizures, muscle spasms, and nausea.

Buy Now

Single User: $5,150 Access to only 1 person; cannot be shared; cannot be printed
Multi User: $7,150 Access for 2 to 5 users only within same department of one company
Enterprise User: $9,150 Access to a company wide audience; includes subsidiary companies or other companies within a group of companies

Need a Discount? Get in touch with us for special pricing

Inquire Before Buying

Connect with our sales team

Why Global Market Insights, Inc.?

Reliability & accuracy

  • GMI is unparalleled when to comes to the quality of research and information provided to clients. Our unique methodology is designed to ensure a minimum of 90% accuracy to give our clients excellent value on their investment.

Quality & trust

  • BBB Rating - Click to Verify

Customer service

  • Over 200 experts are available across various time-zones, ready to serve clients for their research needs. Our industry experts help clients to design reports customized to their needs.

Security & compliance

We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies. More info X